The Wristband that Gives You Superpowers
Neuroscientist David Eagleman aims to give deaf people a new way to hear—and upgrade everyone else’s senses too. by Steven Kotler
Trouble in the High-Rise Hothouse
Big indoor farms are attracting big investments. But transforming agriculture might depend on putting nanofarms everywhere — maybe even in your home. by Corby Kummer
The “Clean Meat” Industry Has a Dirty Little Secret
Manufactured meat may be safer and better — but first, producers need to get rid of the icky ingredients.
Reset Your DNA to Slow the Clock
A new epigenetic test that tracks molecular aging claims to show you how to stay biologically young.
The Latest Biotech Growth Market Might be Crap
There’s gold in your gut—and startups are mining it with microbiome science. The biggest hurdle? Stool doesn’t scale.
This Scientist-Turned-VC Wants to Extend Life
Since he was a child, James Peyer has been obsessed with stopping aging. Now he has a fund — and a plan.
Who Will Be the Google of Genomics?
The first company to offer whole genome sequencing for free can build the most valuable advertising engine in the world. by Andrew Hessel
Arvind Gupta’s Jiu Jitsu Makes Biotech Move at Silicon Valley Speed
He built a powerful system for launching scientific ideas into startups. Can he do it again? by Po Bronson
Get In On the Sale of Yourself
After watching medical records get traded for billions of dollars, a tech entrepreneur says he can help you grab a share of the bounty.
The Clock is Ticking Faster for a Patient Turned Medical Disruptor
Investors and families are counting on Onno Faber to galvanize research into neglected conditions—like the one threatening his hearing and sight.
Where’s the Killer App for Menopause?
Women suffering from hot flashes try to find relief in a device that wasn’t designed specifically for them.
Make the Hospital Come to You
A startup tries to scale up health care that’s cheaper, safer, and much more comfortable.
Machine Learning Illuminates the Body’s Dark Matter
A startup finds patterns that experts in personalized medicine say they couldn’t see before.
Longevity, the Greatest Investment Opportunity of All Time
Billionaire Jim Mellon bets that a “stock market mania” will be sparked by technologies that make people live past 100.